ProShare Advisors
ARVN icon

ProShare Advisors’s Arvinas ARVN Stock Holding History

ProShare Advisors’s Portfolio ARVN Stock Details ARVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,920
Closed -$116K – 1925
2026
Q1 		$116K Sell
10,920
-3,907
-26% -$48.4K ﹤0.01% 1683
2025
Q4 		$176K Buy
14,827
+993
+7% +$10.8K ﹤0.01% 1759
2025
Q3 		$118K Sell
13,834
-2,345
-14% -$17.8K ﹤0.01% 1814
2025
Q2 		$119K Sell
16,179
-830
-5% -$6.11K ﹤0.01% 1844
2025
Q1 		$119K Sell
17,009
-4,340
-20% -$68K ﹤0.01% 1799
2024
Q4 		$409K Buy
21,349
+5,153
+32% +$125K ﹤0.01% 1402
2024
Q3 		$399K Buy
16,196
+5,216
+48% +$136K ﹤0.01% 1277
2024
Q2 		$292K Sell
10,980
-2,852
-21% -$90.9K ﹤0.01% 1305
2024
Q1 		$571K Buy
13,832
+2,188
+19% +$95.6K ﹤0.01% 1011
2023
Q4 		$479K Buy
+11,644
New +$272K ﹤0.01% 1063
2023
Q3 		– Sell
-9,842
Closed -$244K – 1820
2023
Q2 		$244K Buy
9,842
+424
+5% +$10.9K ﹤0.01% 1418
2023
Q1 		$257K Sell
9,418
-1,243
-12% -$39.3K ﹤0.01% 1291
2022
Q4 		$365K Buy
10,661
+823
+8% +$34.6K ﹤0.01% 1121
2022
Q3 		$437K Buy
9,838
+233
+2% +$11.3K ﹤0.01% 953
2022
Q2 		$404K Sell
9,605
-4,720
-33% -$237K ﹤0.01% 1033
2022
Q1 		$964K Sell
14,325
-3,416
-19% -$233K ﹤0.01% 936
2021
Q4 		$1.46M Buy
17,741
+1,640
+10% +$133K ﹤0.01% 862
2021
Q3 		$1.32M Sell
16,101
-4,024
-20% -$356K ﹤0.01% 819
2021
Q2 		$1.55M Buy
20,125
+3,880
+24% +$269K ﹤0.01% 816
2021
Q1 		$1.07M Buy
16,245
+2,336
+17% +$179K ﹤0.01% 942
2020
Q4 		$1.18M Buy
13,909
+4,010
+41% +$138K ﹤0.01% 806
2020
Q3 		$234K Sell
9,899
-331
-3% -$9.59K ﹤0.01% 1329
2020
Q2 		$343K Buy
10,230
+3,618
+55% +$154K ﹤0.01% 1150
2020
Q1 		$266K Sell
6,612
-4,691
-42% -$219K ﹤0.01% 917
2019
Q4 		$464K Buy
+11,303
New +$331K ﹤0.01% 1104

Other funds holding ARVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ProShare Advisors's ARVN Position: Q2 2026 in Review

ProShare Advisors sold out of Arvinas (ARVN) in Q2 2026, closing a stake of 10,920 shares — an estimated $116K sold.

ProShare Advisors first reported a position in ARVN in Q4 2019 and held it in 25 quarters. The position peaked at $1.55M in Q2 2021. 200 funds tracked by Wall St. Rank hold ARVN as of Q2 2026.

  • ProShare Advisors reported no remaining Arvinas position as of Q2 2026 after selling out during the quarter.
  • ProShare Advisors sold 10,920 Arvinas shares in Q2 2026, an estimated $116K.
  • ProShare Advisors first reported a position in Arvinas in Q4 2019 and held it in 25 quarters.
  • ProShare Advisors's Arvinas position peaked at $1.55M in Q2 2021.
  • 200 funds tracked by Wall St. Rank held Arvinas as of Q2 2026.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.